刘坤孟

   职称:讲师、博士后

   研究方向:patent analysis, network analysis, health policy, knowledge flow, real world study and epidemiology study.

   电话:

   通讯地址:山东省青岛市高新区河东路368号青岛蓝色生物医药产业园3号楼 山东中医药大学医学人工智能研究中心

   邮编:266112

   电子邮件:liukunmeng@sdutcm.edu.cn


 

    •  KM Liu, Z Gu, MS Islam, Scherngell T, X Kong, J Zhao, X Chen, Y Hu. Global landscape of patents related to human coronaviruses. International Journal of Biological Sciences. 2021;17(6):1588-99.

   •  KM Liu, HL Zuo, GG Li, H Yu, Y Hu. Global Research on Artemisinin and its Derivatives: Perspectives from Patents. Pharmacological Research, 2020: 105048.

   •  KM Liu, HH Lin, R Pi, S Mak, Y Han, Y Hu. Research and development of anti-Alzheimer’s disease drugs: an update from the perspective of technology flows. Expert opinion on therapeutic patents. 2018 Apr 3;28(4):341-50.

  •  HL Zuo,KG Linghu,YL Wang,KM Liu,Y Gao,H Yu,FQ Yang,YJ Hu. Interactions of antithrombotic herbal medicines with Western cardiovascular drugs.Pharmacological Research,2020:104963

   •  Chan Martin C W,Wang Maggie H,Chen Zigui,Hui David S C,Kwok Angela K,Yeung Apple C M,KM Liu,Yeoh Yun Kit,Lee Nelson,Chan Paul K S.Frequent Genetic Mismatch between Vaccine Strains and Circulating Seasonal Influenza Viruses, Hong Kong,China, 1996–2012. Emerging infectious diseases, 2018, 24(10): 1825.

   •  Yang,L Hou,KM Liu,WB He,Y Cai,FQ Yang,YG Hu.  ChemGenerator: a web server for generating potential ligands for specific targets.Briefings in Bioinformatics. 2020 Dec 31.

   •  Feng, Ye, KM Liu, Liyang Lyu, GJ Sun, and YJ Hu.The Financial Impact of Patents on SMEs in China: Empirical Evidence from Pharmaceutical Sector. Science, Technology and Society (2021): 09717218211047023.